Aldeyra Therapeutics jobs and careers
Lexington, MA, United States
About Aldeyra Therapeutics
Aldeyra Therapeutics develops treatments for aldehyde toxicity-related diseases including Sjögren-Larsson Syndrome (SLS) and noninfectious anterior uveitis.
Founded in 2004 by John E. Dowling and Thomas A. Jordan.
- Founded
- 2004
- Employees
- 11 to 50
- Total funding
- $287.4M
- Headquarters
- Lexington
Leadership
The top of Aldeyra Therapeutics's org chart, with how many people report into each leader.
Todd C. Brady
CEO & President
7 reports
David J. Clark
Chief Medical Officer
2 reports
Christopher Pearson
Vice President, Commercial Development and Strategy
1 report
Charles Montgomery
Senior Director, CMC
David Noskowitz
Vice President, Regulatory Affairs
Board
Jesse I. Treu
Director
Richard H. Douglas
Chairman of the Board
Martin J. Joyce
Director
Ben Bronstein
Director
Neal Walker
Director
Gary Phillips
Director
Jobs at Aldeyra Therapeutics
No open positions right now. Explore more companies on TheJobsMap.